These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8474162)
1. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. Werner A; Levy JA J Virol; 1993 May; 67(5):2566-74. PubMed ID: 8474162 [TBL] [Abstract][Full Text] [Related]
2. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120. Niwa Y; Yano M; Futaki S; Okumura Y; Kido H Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895 [TBL] [Abstract][Full Text] [Related]
3. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334 [TBL] [Abstract][Full Text] [Related]
4. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus. Kido H; Niwa Y; Beppu Y; Towatari T Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754 [TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells. Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181 [TBL] [Abstract][Full Text] [Related]
6. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527 [TBL] [Abstract][Full Text] [Related]
7. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. Sattentau QJ; Moore JP J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252 [TBL] [Abstract][Full Text] [Related]
8. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586 [TBL] [Abstract][Full Text] [Related]
9. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity. McKeating J; Balfe P; Clapham P; Weiss RA J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202 [TBL] [Abstract][Full Text] [Related]
10. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114 [TBL] [Abstract][Full Text] [Related]
11. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. Wyatt R; Thali M; Tilley S; Pinter A; Posner M; Ho D; Robinson J; Sodroski J J Virol; 1992 Dec; 66(12):6997-7004. PubMed ID: 1279195 [TBL] [Abstract][Full Text] [Related]
13. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. Batinić D; Robey FA J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875 [TBL] [Abstract][Full Text] [Related]
14. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. Moore JP; McKeating JA; Huang YX; Ashkenazi A; Ho DD J Virol; 1992 Jan; 66(1):235-43. PubMed ID: 1727487 [TBL] [Abstract][Full Text] [Related]
15. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386 [TBL] [Abstract][Full Text] [Related]
16. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. Thali M; Furman C; Helseth E; Repke H; Sodroski J J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286 [TBL] [Abstract][Full Text] [Related]
18. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. Thali M; Furman C; Ho DD; Robinson J; Tilley S; Pinter A; Sodroski J J Virol; 1992 Sep; 66(9):5635-41. PubMed ID: 1380099 [TBL] [Abstract][Full Text] [Related]
19. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites. Pinter A; Honnen WJ; Tilley SA J Virol; 1993 Sep; 67(9):5692-7. PubMed ID: 7688827 [TBL] [Abstract][Full Text] [Related]